news

BioDuro-Sundia Receives Excellent Partner Award from BioFront Drug Discovery Innovation Center

BioDuro-Sundia has received the award “Excellent Partner 2020” from BioFront Drug Discovery Innovation Center, in recognition of the excellent services ...
February 25, 2021

BioDuro-Sundia Announces New CEO

BioDuro-Sundia names Haijun Dong, PhD, MBA as new CEO. With deep expertise in drug discovery and development, he leads global growth and operational excellence
February 09, 2021

BioDuro-Sundia received the “2020 EXCELLENT Team Service” award from Lynk Pharmaceuticals

We received the “2020 EXCELLENT Team Service” award from Lynk Pharmaceuticals, as recognition of the efforts and contributions made by the drug discovery...
January 18, 2021

Congratulations to DartsBio Pharmaceutical for Analgesic DS002 Injection Approved for Clinical Trial by NMPA

BioDuro Expands Manufacturing Capabilities in China and the US, Enhancing Integrated Drug Development Services Globally. Your trused CRDMO. Moving you Forward
December 25, 2020

Congratulations To GenFleet Therapeutics For Selective CDK9 Inhibitor GFH009 Injection Approved For Clinical Trial by NMPA

CDK9 inhibitor GFH009 Injection has been approved by the CDE (Center for Drug Evaluation), NMPA for clinical trials | BioDuro-Sundia | Moving You Forward
December 21, 2020
Total 89 12...567891011...1718
We use necessary cookies to ensure our website functions properly and to keep it secure. These necessary cookies must be enabled. By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. You can personalize or withdraw your consent at any moment by clicking on the link "Cookies Settings". For more information on how we use cookies, including the total lifespan of cookies and the identity of third parties intervening on our website, please consult the Privacy Notice available in the site footer.
Accept all